SOME CONTEMPORARY ETHICAL CONSIDERATIONS RELATED TO ORGAN-TRANSPLANTATION

被引：9

作者：

COHEN, B

DAMARO, J

机构：

[1] Eurotransplant Foundation, Leiden, NL-2301 CH

[2] Department of Immunohematology and Blood Bank, University Hospital, Leiden, NL-2300 RC

来源：

TRANSPLANT INTERNATIONAL | 1995年 / 8卷 / 03期

关键词：

ALLOCATION; ORGANS FOR TRANSPLANTATION; TRANSPLANTATION; ETHICS; SHORTAGE ORGAN;

D O I：

10.1007/BF00336545

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

With the increasing number of transplantable organs and tissues, as well as improvements in transplantation results. has come a severe shortage of organ donors, Consequently, new ethical dilemmas related to the fair allocation of available organs and the use of alternative sources of donor organs, are of growing concern. Establishing fair allocation priorities is a serious problem in organ transplantation. Ethically, they should be defined by society as a whole rather than exclusively by the medical profession. Proposed solutions for the organ donor shortage, each with their unique ethical constraints. include the use of related donors, partial organ transplantation, cell transplantation using fetal tissue, and the use of animal organs (''senotransplantation''). Commercial trading in donor organs must be regarded as an unethical activity rather than an ethical dilemma since the donors are motivated by monetary rather than by humanitarian reasons. These ethical dilemmas could be largely avoided by an effective reduction in the severe shortage of postmortal organ donations.

引用

页码：238 / 243

页数：6

共 22 条

[11]

McGaw J.L., Wesley A.J., Dilip K.S., Michele H.M., Vinod T.K., Incentives for organ donation?, Lancet, 338, pp. 1441-1443, (1991)

[12]

Michielsen P., Unlimited admission of patients to the waiting list for transplantation, Organ replacement therapy: ethics, justice, commerce, Part V, pp. 364-367, (1990)

[13]

Reidemeister J.C., Zerkowski H.R., Bridging in cardiac surgery: a reasonable surgical procedure or only a method for getting an emergency transplant?, Organ replacement therapy: ethics, justice, commerce, Part VI, pp. 535-540, (1990)

[14]

Schoeppe W., Hypotheses, basal conditions, and facts in the provision and allocation of renal replacement therapy in Germany, Organ replacement therapy: ethics, justice, commerce, Part V, pp. 377-384, (1990)

[15]

Starnes V.A., Lewiston N.J., Luikart H., Theodore J., Stinson E.B., Shumway N.E., Current trends in lung transplantation: lobar transplantation and expanded use of single lungs, J Thorac Cardiovasc Surg, 104, pp. 1060-1065, (1992)

[16]

Sutherland D.E., Goetz F.C., Sibley R.K., Recurrence of disease in pancreas transplants, Diabetes, 38, pp. 85-87, (1989)

[17]

Sutherland D.E.R., Goetz F.C., Gillingham K., Moudry-Munns K.C., Najarian J.S., Medical risks and benefit of pancreas transplants from living related donors, Organ replacement therapy: ethics, justice, commerce, Part II, pp. 93-101, (1990)

[18]

Sutherland D.E.R., Gruessner A., Moudry-Munns K.C., Report on results of pancreas transplantation in the United States, October 1987 to October 1991, from the United Network for Organ Sharing Registry, Clinical transplants, pp. 31-38, (1991)

[19]

Thiel G., Excuses of nephrologists not to transplant, Organ replacement therapy: ethics, justice, commerce, Part V, pp. 353-363, (1990)

[20]

van der Vliet J.A., Slooff M.J.H., Kootstra G., Krom R.A.F., Rijkmans B.G., Non-heartbeating donors: is it worthwhile?, Proc Eur Dial Transplant Assoc, 17, (1980)

← 1 2 3 →